2-208128304-G-GC
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_020989.4(CRYGC):c.423dupG(p.Arg142fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
CRYGC
NM_020989.4 frameshift
NM_020989.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.267
Genes affected
CRYGC (HGNC:2410): (crystallin gamma C) This gene encodes a member of the beta/gamma-crystallin family of proteins. Crystallins constitute the major proteins of vertebrate eye lens and maintain the transparency and refractive index of the lens. This gene and several family members are present in a gene cluster on chromosome 2. Mutations in this gene have been shown to cause multiple types of cataract, including Coppock-like cataract and zonular pulverulent cataract, among others. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-208128304-G-GC is Pathogenic according to our data. Variant chr2-208128304-G-GC is described in ClinVar as [Pathogenic]. Clinvar id is 534186.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRYGC | NM_020989.4 | c.423dupG | p.Arg142fs | frameshift_variant | 3/3 | ENST00000282141.4 | NP_066269.1 | |
LOC100507443 | NR_038437.1 | n.98-8747dupC | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRYGC | ENST00000282141.4 | c.423dupG | p.Arg142fs | frameshift_variant | 3/3 | 1 | NM_020989.4 | ENSP00000282141.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nuclear pulverulent cataract Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 19, 2019 | This variant disrupts the C-terminus of the CRYGC protein. Other variant(s) that disrupt this region (p.Trp157*) have been determined to be pathogenic (PMID: 19204787, 22876111). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This variant has been observed in a family affected with congenital cataract (PMID: 28298635). This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the CRYGC gene (p.Arg142Alafs*22). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 33 amino acids of the CRYGC protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at